Effects of Wood Smoke on Lung Health in Adults
Official title: Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada
Run by University of British Columbia · NCT07536178 · Data updated 2026-11-12
This study tests how different levels of woodsmoke exposure affect lung function and inflammatory responses in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 80 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Status | Recruiting |
| Started | May 26, 2026 |
| Main results expected | August 31, 2029 |
| Study ends | August 31, 2030 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07536178 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults 19–80 years old without current or past respiratory diseases or confounding medical conditions, and not pregnant.
✕Probably not a fit
Individuals with current respiratory illnesses or certain comorbidities may not benefit and could be excluded due to safety considerations.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study uses controlled human exposures to woodsmoke (from Lodgepole Pine) at three concentrations and a filtered-air control to explore potential links between wildfire smoke and chronic lung diseases. Participants are healthy adults aged 19 to 80 and will undergo 2-hour exposure sessions over multiple days with varying PM2.5 levels. The goal is to understand how exposure concentration, intensity, and duration influence lung function, inflammation, and immunomodulatory responses, building biological plausibility for connections to asthma, COPD, and lung cancer. Findings may shed light on which individuals are most vulnerable to wildfire smoke and the mechanisms behind long-term respiratory effects.
Why it matters
Potential benefit: If successful, the study could improve understanding of who is most at risk from wildfire smoke and inform public health guidance and protective strategies.
How similar studies have gone: Previous research in controlled smoke exposures has provided mechanistic insights, though this exact WFS exposure model in healthy adults is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy Adults between the ages of 19 to 80 (12 of each biological sex assigned at birth). Exclusion Criteria: 1. Current smoker (within six months before screening; potential to confound exposure effects). 2. History or current diagnosis of any respiratory conditions (including, but not limited to asthma or chronic obstructive pulmonary disease (COPD), asthma/COPD overlap) or other medical conditions that the study physician determines may impact participant safety. 3. Any comorbidities or other concerns identified by the study physician which may impact study participation. 4. For participants of child-bearing potential: Current pregnancy, or plans to become pregnant during study enrolment.
Where it's running
-
Air Pollution Exposure Lab
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Principal investigator: Chris Carlsten, MD, MPH — University of British Columbia
- Study coordinator: PJ (Parteek) Johal, BCS
- Email: p.johal@ubc.ca
- Phone: 604-875-5132
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Breztri real-world safety and effectiveness in Korean patients with COPD or asthma
This post-marketing study tests Breztri in real-world Korean patients with COPD or asthma to see how safe it is and how well it works when used as usual care.
-
Finding undiagnosed chronic lung problems in people with other long-term health conditions in Brazil
This project will try two short questionnaires (COLA and SBQ) plus breathing tests to find undiagnosed asthma, COPD, or similar lung problems in people with long-term conditions who attend primary care in São Carlos and São Paulo, Brazil.
-
Understanding airway mucus blockages in asthma, COPD, and chronic cough across Canada
This project will use chest CT scans and clinical data to see if mucus plugs in the airways are linked to symptoms in adults with moderate-to-severe asthma, COPD, or chronic cough.
-
Understanding the impact of multimorbidity on chronic airway diseases
This study looks at how having multiple health issues affects people with chronic lung diseases like COPD, asthma, or bronchiectasis to help improve their care and treatment.
-
SELF-BREATHE: a self-guided online program to reduce chronic breathlessness in adults
This study will test whether SELF-BREATHE, a self-guided internet-based support program, can help adults with chronic breathlessness from lung or heart conditions breathe easier and feel less distressed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.